ghk-cu peptide sciences BPC-157, TB-500, 30mg Glow Blend GHK-Cu Research Guide: Copper Peptide

Disclosure of interest: Xinjie Gao: nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P158 - ESOC25-1869 ACCURACY OF AUTOMATED HEMORRHAGE SUBTYPE DETECTION IN SUSPECTED INTRACEREBRAL HEMORRHAGE James Garrard 1,2 , Artem Kaliaev 3 , Asim Mian 3 , Chad Farris 3 , Pau Bellot 1 , Olivier Joly 1 , Zoe Woodhead 1 , James Briggs 1,4 , Davide Carone *1 , George Harston 1,2 , Mohamad Abdalkader 3 1 Brainomix, OXFORD, United Kingdom, 2 Oxford University Hospitals, OXFORD, United Kingdom, 3 Boston Medical Centre, Boston, United States, 4 Royal Berkshire Hospital, Reading, United Kingdom Background and Aims: Early identification of patients with intracerebral hemorrhage (ICH) is thought to be critical to improve outcomes through earlier implementation of evidence-based care-bundles

10.1210/clinem/dgz324 50 SmitD

This once-daily treatment consists of dissolving your medication on the side of your cheek/mouth and has been proven to significantly reduce common side effects, such as nausea and stomach pain, experienced with injections

Some people may experience mild complaints, for example from the digestive system, or allergic reactions